Alembic receives FDA final approval for Betamethasone Valerate Foam, 0.12%

Sequent Scientific receives WHO prequalification approval for Albendazole API

This is in partnership with Mepro Pharmaceuticals which have successfully developed and commercialised the Albendazole Chewable formulation

Alembic receives USFDA’s final approval for Fluphenazine Hydrochloride Tablets

Voydeya approved in the EU as add-on treatment to ravulizumab

ALPHA Phase III trial showed first-in-class, oral, Factor D inhibitor as add-on to Ultomiris or Soliris improved haemoglobin levels and reduced anaemia and fatigue

Merck Animal Health receives positive CVMP opinion for an injectable formulation of Bravecto

The CVMP recommends the product for approval for the treatment and persistent killing of fleas

Alembic received 6 USFDA approvals during Q2FY24

The company has received six final approvals that includes Chlorpromazine Hydrochloride Tablets

Ojjaara approved in the US as the first and only treatment for myelofibrosis patients with anaemia

Approval is for use in myelofibrosis patients with anaemia regardless of prior myelofibrosis therapy

Apollo introduces India's first comprehensive Connected Care Services

This indigenously developed enhanced care technology is designed to continuously monitor and detect early signs of deterioration in a patient's condition

Elekta and IAEA partner to improve access to cancer care in underserved countries

Dr. Laurent Leksell, Elekta’s Founder and Chairman of the Board, and IAEA’s Director General, Dr. Rafael Mariano Grossi meet in Stockholm to discuss reducing the global cancer burden

Jan Aushadhi Train flagged off by Mandaviya and Vaishnaw in New Delhi

Jan Aushadhi highlights achievements of women of the country at 34 locations by felicitating all women stakeholders under the scheme